Navigation Links
Max Institute of Minimal Access, Metabolic & Bariatric Surgery Accredited as an International Centre of Excellence for Minimal Invasive Surgery
Date:6/17/2011

RESEARCH TRIANGLE PARK, N.C., June 17, 2011 /PRNewswire/ -- Max Neeman International, leading Indian CRO, is part of the prestigious Max Group whose sister-company, Max Healthcare recently had one of 12 hospitals, 'Max Institute of Minimal Access, Metabolic & Bariatric Surgery' accredited as a Center of Excellence (COE) by the Surgical Review Corporation (SRC), USA.  The institute has become the first center in India to receive the accreditation.

(Logo: http://photos.prnewswire.com/prnh/20110105/CL25129LOGO)

The Institute's medical team is comprised of 45 people led by Dr. Pradeep Chowbey. They bring with them an accumulated experience of over 48,000 laparoscopic and bariatric surgeries spanning over two decades. The team has been at the forefront to develop and expand the frontiers of minimal access surgery in the country and beyond.

Dr. Chowbey, was featured in the Limca Book of Records from 2000 - 2009, for having performed the largest series of laparoscopic biliary surgeries (over 50,000). He has also been awarded the first honorary membership by Asia-Pacific Hernia Society and Gulf Cooperation Council Hernia Society.  The medical team is proud of having had the honor of operating on His Holiness, The Dalai Lama and His Excellency, Shri K R Narayanan, the former President of India.

As the clinical research arm of the Max Group, Max Neeman works in collaboration with Max Institute of Minimal Access, Metabolic & Bariatric Surgery to conduct minimally invasive surgery studies across multiple therapeutic areas. This collaboration provides global device and pharmaceutical companies with an integrated service offering by leveraging the combined knowledge and experience of both Max Neeman and Max Healthcare to reaffirm our commitment in setting standards of excellence in all facets of patient care.

About Max Healthcare

With over 930 beds, 12 hospitals, 1500 physicians and 3500 support staff - Max Healthcare is one of a leading chain of hospitals in India. Its state of the art infrastructure, over 275 ICU beds and most advanced technologies makes it one of the best hospitals in India. http://www.maxhealthcare.in

About Max Neeman International

Max Neeman International is a leading CRO in India. Our specialty is that we offer services for the successful conduct of Phase II-IV clinical and device trials for small and mid-sized Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2008 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 175 sites across 31 cities with 6 regional offices.  Contact Donald Swankie, Vice President USA at 919.424.3345 / Donald.swankie@neeman-medical.com.

Max Institute of Minimal Access, Metabolic & Bariatric Surgery, Max Healthcare, New Delhi, India is the first of its kind in the subcontinent and globally recognized to be a center of excellence in endosurgery. The Institute is comprised of surgeons who specialize in various areas and are dedicated to performing surgical procedures with a special emphasis on utilization of minimal access techniques (Laparoscopy Surgery), so that patients reap the benefits of faster recovery, lesser post-operative pain and minimal post-surgical complications.


'/>"/>
SOURCE Max Neeman International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development
2. Arteriocyte and the U.S. Army Institute of Surgical Research (USAISR) Sign a CRADA to Speed Development of Cellular Therapies for Orthopaedic Trauma
3. Ontario Institute for Cancer Research Announces Spin Off Companies Developing Promising Anticancer Technologies
4. Ludwig Institute for Cancer Research and Polaris Group Form Collaboration to Expand Development of Polaris Novel Cancer Drug, ADI-PEG 20
5. Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe
6. Larta Institute Receives Award for National Institutes of Health Commercialization Assistance Program at 2011 Acquisition, Grants, and Small Business Symposium
7. Van Andel Institute Earns Highest "Green Building" Award
8. LifeNet Health Breaks Ground on New Institute of Regenerative Medicine
9. The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting
10. MabVax Therapeutics Receives $1.8 Million in a Phase 2 Small Business Innovation Research Program Award From the National Cancer Institute
11. IBM and The Institute of Bioengineering and Nanotechnology Find Breakthrough for MRSA Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  HedgePath Pharmaceuticals, Inc. ... discovers, develops and plans to commercialize innovative therapeutics ... of common stock were approved for trading on ... trading on the OTCQX, effective today, under the ... the OTCQX market, companies must meet high financial ...
(Date:12/8/2016)... , Dec. 8, 2016  Partnering to fuel ... Ben Franklin Technology Partners of Southeastern Pennsylvania ... ("IHG"), the parent company of Independence Blue Cross; and ... announced their intentions for a $6 million funding initiative ... healthcare startups. Responding to a burgeoning economic ...
(Date:12/7/2016)... ... December 07, 2016 , ... A ... “in the setting of previously treated, advanced pancreatic cancer, liquid biopsies are not ... patient population and timing of blood sampling may improve the value of a ...
(Date:12/7/2016)... , Dec. 7, 2016 /PRNewswire/ - OncoQuest ... development and commercialization of immunotherapeutic products for the ... entered into an Antibody Manufacturing Development Program with ... , USA) for its oregovomab antibody product. Supported ... Phase IIb clinical study in ovarian cancer patients, ...
Breaking Biology Technology:
(Date:11/17/2016)... Market Watch: Primarily supported by ownership types; Private ... market is to witness a value of US$37.1 billion by ... Annual Growth Rate (CAGR) of 10.75% is foreseen from ... North America is not way behind ... at 9.56% respectively. Report Focus: The ...
(Date:11/15/2016)... , Nov 15, 2016 Research and ... Global Forecast to 2021" report to their offering. ... ... USD 16.18 Billion by 2021 from USD 6.21 Billion in 2016, ... Growth of the bioinformatics market is driven by the ...
(Date:6/22/2016)... BETHESDA, Md. , June 22, 2016  The American ... by Trade Show Executive Magazine as one of ... Summit on May 25-27 at the Bellagio in ... based on the highest percentage of growth in each of ... number of exhibiting companies and number of attendees. The 2015 ...
Breaking Biology News(10 mins):